Sale of Secondary Common Shares in KRY International AB
Stadsholmen Equity
7 Aug 2023
Stadsholmen Equity is proud to have acted as equity broker in several secondary transactions in the health tech company Kry. We would like to thank the parties involved in the transactions for their confidence in us, and we look forward to following the future journey of the company.
Kry, founded in 2014, is Europe's leading digital-first healthcare provider. The company digitize the patient meeting to improve accessibility and quality of healthcare.
With its foundation in digital, the company has recently expanded its offer also to include physical care, in order to be a provider throughout the entire patient journey. In mid-2022, Kry reached the milestone of 8 million patient consultations, and today they have over 5,000 medical doctors, nurses and psychologists as well as +50 physical health care centres contributing to the turnover of SEK ~2.4bn.
Like many of its peers, Kry has been focusing on profitability over growth for some time, with a 20 percentage points improved group EBITDA margin over the past two quarters. The Nordic operations have been profitable since Q1(23), and the company is working towards profitability in France — where they have also achieved a milestone of over 1 million patient consultations since their launch in 2018. Despite tightening measures to focus on profitability, the company has surpassed their goal in terms of number of registered patients.